Phathom Pharmaceuticals, Inc. — Director's Dealing 2019

Oct 25, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2019-10-24

Reporting Person: FIELDS HEIDI (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$13.04	2029-09-25	Common Stock (43360)		Direct

Footnotes

F1: The option will vest with respect to 25% of the shares of common stock on September 26, 2020, and will vest with respect to the remaining shares in equal monthly installments over the following three years.